The BK virus (BKV) infection diagnostics market consists of tests and assays used to detect BKV infection in humans. BKV is a pathogenic polyomavirus that commonly infects humans and usually remains latent after the primary infection. However, BKV reactivation can occur in immunocompromised individuals such as transplant recipients, leading to diseases like nephropathy, cystitis, and hemorrhagic cystitis. Growing prevalence of sexually transmitted diseases and rising number of organ transplant procedures are triggering the risk of BKV infection, thereby propelling the demand for effective diagnostic assays.
The global BKV Virus Infection Market is estimated to be valued at US$ 56 million in 2024 and is expected to exhibit a CAGR of 41% over the forecast period 2024-2032.
Key Takeaways
Key players operating in the BK virus (BKV) infection diagnostics market are Qiagen, Abbott, bioMerieux, F. Hoffmann-La Roche Ltd. and Thermo Fisher Scientific.
Increasing adoption of viral detection assays and growing access to healthcare in emerging nations present lucrative opportunities for players in this market. Rapid diagnostic kits with high sensitivity and affordability could drive further adoption.
The rising volume of kidney transplants globally will boost the diagnostic demand in Asia Pacific and Latin America. Improving reimbursement scenario will encourage market players to strengthen their presence across hospitals and diagnostic laboratories through partnerships.
Market drivers
The rising prevalence of sexually transmitted diseases such as HIV has significantly increased the risk of BKV infection, driving the need for reliable diagnostic testing. As per the World Health Organization, over 1 million new cases of curable STDs occur every day globally. Similarly, the growing elderly population susceptible to renal impairment is augmenting the number of kidney transplant procedures worldwide, thereby propelling the BKV infection diagnostics market.
PEST Analysis
Political: Regulations around testing and treatment of BKV infections directly impact the market. Recent changes in guidelines have increased testing.
Economic: Rising healthcare costs in many countries are driving demand for affordable treatment options. The economic burden of BKV infections provides opportunities.
Social: Increased awareness about transplant-associated infections has reduced the stigma around BKV. Social media is now a important platform for patients to share experiences.
Technological: Advanced molecular diagnostic techniques allow early and accurate detection of BKV. Development of vaccines and targeted antiviral therapies rely on technological innovations.
Geographical regions of concentration
North America accounts for the largest share of the global BK virus infection market, both in terms of value and volume. This can be attributed to factors such as the rising healthcare expenditure, high number of organ transplant procedures, and growing geriatric population in the US and Canada.
Fastest growing region
The Asia Pacific region is expected to witness the highest growth over the forecast period owing to growing healthcare infrastructure, rising medical tourism, increasing incidence of organ transplant procedures, expanding patient pool, and improving access to healthcare in emerging Asian countries.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals.